This study evaluates the efficacy of the HIFU for the treatment of breast fibroadenoma with the FastScan version using assessment of patient experience and adverse event reporting.
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of participants with adverse events
Timeframe: 1 day post treatment
Number of participants with adverse events
Timeframe: 3 days post treatment
Number of participants with adverse events
Timeframe: 7 days post treatment
Change from Baseline volume of the fibroadenoma at 6 months
Timeframe: 6 months post treament
Change from Baseline Patient pain intensity score (100mm visual analog scale) at 1 day
Timeframe: 1 day post treatment
Change from Baseline Patient pain intensity score (100mm visual analog scale) at 3 days
Timeframe: 3 days post treatment
Change from Baseline Patient pain intensity score (100mm visual analog scale) at 7 days
Timeframe: 7 days post treatment
Patient satisfaction questionnaire
Timeframe: 6 months post treatment